alexa Jan-Willem Taanman
ISSN: 2167-7700

Chemotherapy: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Jan-Willem Taanman

Dr.Jan-Willem Taanman
Reader in Clinical Neurosciences
Clinical Neuroscience Institute of Neurology
Faculty of Brain Sciences

Dr.Jan-Willem Taanman readedr in University Department of Clinical Neurosciences, Institute of Neurology, UCL. My research interests are experimental cell culture models of neurodegenerative disease, including Parkinson's disease and mitochondrial encephalomyopathies. 1982 BSc Bachelor of Science – Plant Pathology. 1991 PhD Doctor of Philosophy – Cell Biology and Biochemistry, 1985 MAS Masters – Plant Pathology. Dr. Jan-Willem Taanman and his team at the University College of London, U.K. are conducting UMDF-funded research to characterize in greater detail the assembly pathway of cytochrome-c oxidase, an important enzyme involved in mitochondrial ATP synthesis. Taanman research focuses mainly on the biogenesis of mitochondria and the role of mitochondria in disease. Dr. Jan-Willem Taanman has over 115 peer reviewed publications.

Research Interest

biogenesis of mitochondria and the role of mitochondria in disease


Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version